PL1841458T3 - Schemat stosowania środka powierzchniowo czynnego do leczenia lub zapobiegania dysplazji oskrzelowo-płucnej - Google Patents

Schemat stosowania środka powierzchniowo czynnego do leczenia lub zapobiegania dysplazji oskrzelowo-płucnej

Info

Publication number
PL1841458T3
PL1841458T3 PL06717499T PL06717499T PL1841458T3 PL 1841458 T3 PL1841458 T3 PL 1841458T3 PL 06717499 T PL06717499 T PL 06717499T PL 06717499 T PL06717499 T PL 06717499T PL 1841458 T3 PL1841458 T3 PL 1841458T3
Authority
PL
Poland
Prior art keywords
treating
bronchopulmonary dysplasia
treatment regimen
surfactant treatment
preventing
Prior art date
Application number
PL06717499T
Other languages
English (en)
Inventor
Anthony Killian
Christopher Schaber
Robert Segal
Carlos Guardia
Original Assignee
Discovery Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36169079&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1841458(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Discovery Lab Inc filed Critical Discovery Lab Inc
Publication of PL1841458T3 publication Critical patent/PL1841458T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/395—Alveolar surfactant peptides; Pulmonary surfactant peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
PL06717499T 2005-01-06 2006-01-06 Schemat stosowania środka powierzchniowo czynnego do leczenia lub zapobiegania dysplazji oskrzelowo-płucnej PL1841458T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64180505P 2005-01-06 2005-01-06
EP06717499A EP1841458B9 (en) 2005-01-06 2006-01-06 Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
PCT/US2006/000308 WO2006074296A1 (en) 2005-01-06 2006-01-06 Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia

Publications (1)

Publication Number Publication Date
PL1841458T3 true PL1841458T3 (pl) 2012-05-31

Family

ID=36169079

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06717499T PL1841458T3 (pl) 2005-01-06 2006-01-06 Schemat stosowania środka powierzchniowo czynnego do leczenia lub zapobiegania dysplazji oskrzelowo-płucnej

Country Status (13)

Country Link
US (1) US7541331B2 (pl)
EP (2) EP2298349A1 (pl)
JP (2) JP2008526868A (pl)
AT (1) ATE538814T1 (pl)
AU (1) AU2006203978B2 (pl)
CA (1) CA2593758A1 (pl)
CY (1) CY1112769T1 (pl)
DK (1) DK1841458T3 (pl)
ES (1) ES2380046T3 (pl)
PL (1) PL1841458T3 (pl)
PT (1) PT1841458E (pl)
SI (1) SI1841458T1 (pl)
WO (1) WO2006074296A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9486429B2 (en) * 1999-06-01 2016-11-08 Vanderbilt University Therapeutic methods employing nitric oxide precursors
US6346382B1 (en) 1999-06-01 2002-02-12 Vanderbilt University Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
EP2063903A1 (en) * 2006-09-19 2009-06-03 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
US20080142010A1 (en) * 2006-09-20 2008-06-19 Next Safety, Inc. Systems, methods, and apparatuses for pulmonary drug delivery
US20080066739A1 (en) * 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
US20080078382A1 (en) * 2006-09-20 2008-04-03 Lemahieu Edward Methods and Systems of Delivering Medication Via Inhalation
US7951781B2 (en) * 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
US8048043B2 (en) * 2007-06-08 2011-11-01 Chiesi Farmaceutici S. P. A. Method of administration of a pulmonary surfactant
AU2014204490B2 (en) * 2008-01-31 2016-05-12 Vanderbilt University Therapeutic treatment for lung condtions
JP5623916B2 (ja) 2008-01-31 2014-11-12 バンダービルト・ユニバーシティＶａｎｄｅｒｂｉｌｔ Ｕｎｉｖｅｒｓｉｔｙ 動脈瘤性くも膜下出血及び血管痙攣に対する医薬組成物
KR20170005155A (ko) * 2008-01-31 2017-01-11 반더빌트유니버시티 폐의 용태에 따른 치료 방법
US9044392B2 (en) * 2010-03-19 2015-06-02 Wisconsin Alumni Research Foundation Nylon-3 co-polymers and synthetic lung surfactant compositions containing same
US20190175502A1 (en) * 2015-10-20 2019-06-13 Indiana University Research & Technology Corporation Methods and compositions for treating lung disease of prematurity
CA3043792A1 (en) * 2016-12-22 2018-06-28 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid for the treatment of evolving bpd
KR102781186B1 (ko) * 2018-04-23 2025-03-17 키에시 파르마슈티시 엣스. 피. 에이. Bpd의 예방을 위한 폐 계면활성제 및 스테로이드를 포함하는 치료학적 조합물
KR102173673B1 (ko) * 2018-05-04 2020-11-03 사회복지법인 삼성생명공익재단 기관지 폐 이형성증 (bpd) 예방 또는 치료용 물질 스크리닝 방법
US12440471B2 (en) * 2021-07-30 2025-10-14 Ayuvis Research, Inc. Compositions and methods for the treatment of bronchopulmonary dysplasia (BPD) and BPD-associated pulmonary hypertension

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US502495A (en) 1893-08-01 klijsel
US5840527A (en) 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
US4659805A (en) 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US4918161A (en) 1985-09-26 1990-04-17 Genetics Institute, Inc. Low molecular weight pulmonary surfactant proteins
IT1203873B (it) 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
ATE163013T1 (de) 1987-11-04 1998-02-15 Byk Gulden Lomberg Chem Fab Alveolare oberflächenaktive proteine
US5260273A (en) 1988-01-06 1993-11-09 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US6013619A (en) 1988-01-06 2000-01-11 The Scripps Research Institute Pulmonary surfactants and therapeutic uses, including pulmonary lavage
US6613734B2 (en) 1988-01-06 2003-09-02 The Scripps Research Institute Peptides-containing liposomal surfactants
US5164369A (en) 1988-01-06 1992-11-17 The Scripps Research Institute Pulmonary surfactant protein and related polypeptide
US4861756A (en) 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
SE8803713D0 (sv) 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
US5006343A (en) 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
US5238920A (en) 1989-08-22 1993-08-24 Abbott Laboratories Pulmonary surfactant protein fragments
DE69125750D1 (de) 1990-05-21 1997-05-28 Abbott Lab Fettsäure-Oberflächenaktives-Lungenprotein Konjate
US5272252A (en) 1991-11-04 1993-12-21 Merrell Dow Pharmaceuticals Inc. Synthetic lung surfactant having antioxidant properties
ES2192190T3 (es) 1992-04-10 2003-10-01 Abbott Lab Fragmentos proteicos tensioactivos pulmonares.
US5302481A (en) 1993-06-07 1994-04-12 Xerox Corporation Toner compositions with negative charge enhancing complexes
DK0733645T3 (da) 1993-12-08 2003-07-14 Mitsubishi Pharma Corp Syntetisk peptid, lungeoverfladeaktivt stof indeholdende dette og præparat mod respiratory distress syndrome
DE4418936A1 (de) 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
DE4434629C1 (de) 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5863563A (en) * 1994-10-20 1999-01-26 Alphagene Inc. Treatment of pulmonary conditions associated with insufficient secretion of surfactant
US6562781B1 (en) * 1995-11-30 2003-05-13 Hamilton Civic Hospitals Research Development Inc. Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
US6660833B1 (en) 2000-02-29 2003-12-09 Harbor-Ucla Research And Education Institute Respiratory distress syndrome therapy with peptide analogs of human SP-B
US6884777B1 (en) 2000-11-14 2005-04-26 The Nemours Foundation Method for treating respiratory distress syndrome
JP2004305006A (ja) * 2003-04-01 2004-11-04 Japan Science & Technology Agency 人工調製肺サーファクタント
WO2005115520A1 (en) * 2004-05-20 2005-12-08 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
WO2006026237A1 (en) 2004-05-20 2006-03-09 Discovery Laboratories, Inc. Methods, systems and devices for noninvasive pulmonary delivery

Also Published As

Publication number Publication date
AU2006203978A1 (en) 2006-07-13
EP1841458B1 (en) 2011-12-28
US20060194728A1 (en) 2006-08-31
SI1841458T1 (sl) 2012-04-30
ATE538814T1 (de) 2012-01-15
AU2006203978B2 (en) 2011-11-03
EP2298349A1 (en) 2011-03-23
DK1841458T3 (da) 2012-04-23
US7541331B2 (en) 2009-06-02
JP2013177422A (ja) 2013-09-09
ES2380046T3 (es) 2012-05-08
CA2593758A1 (en) 2006-07-13
EP1841458A1 (en) 2007-10-10
HK1109078A1 (en) 2008-05-30
EP1841458B9 (en) 2012-12-12
PT1841458E (pt) 2012-04-10
WO2006074296A1 (en) 2006-07-13
CY1112769T1 (el) 2016-02-10
JP2008526868A (ja) 2008-07-24

Similar Documents

Publication Publication Date Title
SI1841458T1 (sl) Zdravljenje s predpisanim odmerjanjem surfaktanta za zdravljenje ali preprečevanje bronhopulmonalne displazije
CY1110353T1 (el) Ανοσορρυθμιστικοι ολιγοσακχαριτες
NO20072733L (no) Doseformer
CY2015024I2 (el) Παραγωγα ινδολιδονης για την θεραπεια ή προληψη ινωτικων ασθενειων
NO20070049L (no) Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese
AP2378A (en) Sulfonamide derivatives for the treatment of diseases.
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
BRPI0606524A2 (pt) derivados de indol para o tratamento de infecções virais
AP2359A (en) Sulfonamide derivatives for the treatment of diseases.
DK1819353T3 (da) Sammensætning til proteasomhæmning
ES2611286T8 (es) Régimen de dosis variables múltiples para el tratamiento de enfermedad de Crohn y colitis ulcerosa
CY2018006I1 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
NO20064732L (no) Alfa-aminoamidderivater nyttige i behandlingen av urolige bein-syndromet og additive lidelser
NO20041024D0 (no) Anvendelse av BIBN4096 i kombinasjon med andre antimigrenelegemidler for behandling av migrene
DK1670489T3 (da) Brug af xenon med hypotermi til behandling af neonatal asfyksi
TW200716146A (en) Method for treating or preventing systemic inflammation in formula-fed infants
IL182055A0 (en) Agent for prophylaxis or treatment of metabolic syndrome
NO20052814D0 (no) Cytomodulerende peptider for behandling av interstitielle cystitt
DK1523985T3 (da) Ikke-radioaktivt strontiumholdigt middel til behandling af kræft
CY1109771T1 (el) Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες
NO20042542L (no) Anvendelse av ascomycin for behandling av blefarit
SE0303236L (sv) Förfarande för behandling av aska för gödningsändamål
ATE447018T1 (de) Hochsichere intranasal verabreichbare genimpfstoffe zur behandlung von morbus alzheimer
IL176564A0 (en) Sulfonamide derivatives for the treatment of diseases